Getting new drugs to people with AIDS: a public policy response to Lansdale.

Addressing the Needs of Sexual Partners of People Who Inject Drugs through Peer Prevention Programs in Iran

Despite the fact that HIV epidemic is mainly driven by injection drug use in Iran, partners of People Who Inject Drugs (PWID) have been seriously neglected in terms of effective preventive interventions. Currently, sexual partners of PWID might have access to some harm reduction services at Voluntary Counselling and Testing (VCT) centers; however, their needs have not been effectively targeted ...

Governance of HIV/AIDS: Implications for Health Sector Response

This paper reviews the essence of effective governance and importance of a multi-sectoral approach in generating health systems response to HIV/AIDS. This comprehensive approach highlights the importance of integrating reproductive sexual health programs and HIV prevention services, including peer education, life skills, and Voluntary Counseling and Testing (VCT), for Prevention of Mother–to-Ch...

Brazil and access to HIV/AIDS drugs: a question of human rights and public health.

I explore the relationship between public health and human rights by examining the Brazilian government's policy of free and universal access to anti-retroviral medicines for people with HIV/AIDS. The Brazilian government's management of the HIV/AIDS epidemic arose from initiatives in both civil society and the governmental sector following the democratization of the country. The dismantling of...

BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management

BRIC nations – Brazil, Russia, India, and China – represent 40% of the world’s population, including a growing aging population and middle class with an increasing prevalence of chronic disease. Their healthcare systems increasingly rely on prescription drugs, but they differ from most other healthcare systems because healthcare expenditures in BRIC nations have exhibited the highest revenue gr...

The Health Policy and Management (HPAM) Gap- From Diagnosis to Prescription: A Response to Recent Commentaries